AVM Biotechnology

Founded in Seattle, AVM Biotechnology is a development-stage biotech company dedicated to advancing stem cell technologies for regenerative medicine and cancer treatment recovery. Their core mission is to address high unmet medical needs through innovative solutions, including safer iPS cell culturing and fully human biologics. AVM focuses on developing game-changing therapies that enhance patient outcomes in areas such as acute respiratory distress syndrome (ARDS) and infectious diseases.

AVM Biotechnology has garnered attention for its pioneering research and development efforts. The company is supported by notable investors and has established partnerships to further its clinical trials and compassionate use programs. Key achievements include significant advancements in stem cell technology applications and the initiation of multiple clinical trials aimed at improving cancer treatment recovery. AVM's impact lies in its potential to revolutionize regenerative medicine and offer safer, more effective treatment options for patients worldwide.